Regeneron Pharmaceuticals, Inc.
Diversified biotechnology company with commercial antibody franchises and a broad late-stage pipeline in oncology, immunology and rare disease.
Immunology, oncology & rare disease · Monoclonal and bispecific antibodies; gene silencing & editing · Commercial + Phase 3